Clinical Trial Update: Clinical Study to Investigate the Safety and Efficacy of MLC601 in 150 Iranian Patients After Stroke [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated the safety and efficacy of MLC601 in 150 Iranian patients after stroke and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• MLC601

Snippet

Sponsor: Shahid Beheshti University | Conditions: Stroke | Phase 4 | Status: COMPLETED